Matthew Wikler - Dec 31, 2021 Form 4 Insider Report for Matinas BioPharma Holdings, Inc. (MTNB)

Role
Director
Signature
/s/ Keith A. Kucinski, attorney-in-fact for Matthew Wikler
Stock symbol
MTNB
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
4
Date filed
1/3/2022, 04:45 PM
Previous filing
Nov 2, 2021
Next filing
Nov 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTNB Common Stock Award $0 +7.86K +2.78% $0.00 290K Dec 31, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 31, 2021, the Reporting Person was issued 7,859 shares of common stock, par value $0.0001 per share, pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant.